Publications in VIVO

Guerrero-Beltrán, Carlos Enrique

share the uri qr icon


Dr. Enrique Guerrero Beltrán Research Areas ----- Immunomodulatory mechanisms mediated by the use of nanoparticles, proteins, peptides and genetic material, ----- Cytotoxicity mediated by nanomaterials and chemical agents, ----- Antioxidant, anti-inflammatory, anti-fibrotic and cell death mechanisms by natural compounds in cardiovascular pathologies. Email: Dr. Enrique Guerrero, has a degree in Experimental Biology (Bachelor in Biology) of Universidad Autónoma de Sinaloa (UAS) and a Bachelor Degree in Music (Piano) by the same institution (UAS). He has a Master degree in Sciences and a Doctoral Degree in Sciences from the Faculty of Chemistry by Universidad Nacional Autónoma de México (UNAM). He did a research stay at The National Institutes of Health / National Institute on Alcohol Abuse and Alcoholism (NIH / NIAAA) in Maryland. He was a postdoctoral researcher at the Departament de Fisiología, Biofísica y Neurociencias del Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN). On the other hand, he made a postdoctoral stay in the Cardiovascular Medicine group of Tecnológico de Monterrey. He was a Professor-Postdoc within the focus group in Molecular Medicine and was a Postdoctoral Researcher at the Department of Nanomedicine at the Houston Methodist Research Institute in Houston, Texas. USA. Currently, Dr. Guerrero Beltrán is a full-time Research Professor at the Medical School of Tecnológico de Monterrey. Dr. Enrique Guerrero is a member of the Mexican System of Researchers (Level 1). He has published 15 articles with more than 350 citations, in biochemical and biomedical areas. He has been a reviewer for Editorial Planeta and is a reviewer at the British Journal of Pharmacology. His work as a researcher deals with the study, in vitro and in vivo, of the immunomodulatory mechanisms mediated by the use of nanoparticles, proteins, peptides and genetic material, the toxic and pro-oxidant effects through the use of nanomaterials and chemical agents, as well as the antioxidant, anti-inflammatory, antifibrotic and cell death mechanisms mediated by natural compounds in cardiovascular pathologies such as heart failure. Reference pages: and

Research Areas research areas

Selected publications